Mycophenolic acid for psoriasis.

Abstract	Mycophenolic acid is an antimetabolite used experimentally for the treatment of psoriasis. Thirty-eight patients were treated with mycophenolic acid. A double-blind, placebo-controlled study demonstrated the efficacy of mycophenolic acid (P less than .01). A long-term safety study showed the occurrence of hematologic abnormalities, viral infections, and carcinoma. The position of mycophenolic acid in the therapeutic treatment of psoriasis must await the results of a multicenter cooperative study.
Authors	W S Lynch, H H Roenigk Jr
Journal	Archives of dermatology (Arch Dermatol) Vol. 113 Issue 9 Pg. 1203-8 (Sep 1977) ISSN: 0003-987X [Print] United States
PMID	332090 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References	Mycophenolic Acid
Topics	Adolescent Adult Aged Breast Neoplasms (chemically induced) Carcinoma, Squamous Cell (chemically induced) Clinical Trials as Topic Double-Blind Method Epiglottis Female Humans Laryngeal Neoplasms (chemically induced) Male Middle Aged Mycophenolic Acid (adverse effects, pharmacology, therapeutic use) Psoriasis (drug therapy) Virus Diseases (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!